Serum levels of lamotrigine during delivery in mothers and their infants

被引:19
|
作者
Kacirova, Ivana [1 ]
Grundmann, Milan
Brozmanova, Hana
机构
[1] Univ Ostrava, Univ Hosp Ostrava, Fac Med, Dept Clin Pharmacol, CZ-70852 Ostrava, Czech Republic
关键词
Lamotrigine; Therapeutic drug monitoring; Epilepsy; Delivery; ANTIEPILEPTIC DRUGS; HUMAN PLACENTA; PREGNANCY; PHARMACOKINETICS; LOCALIZATION; EXPRESSION; CLEARANCE; LACTATION;
D O I
10.1016/j.eplepsyres.2010.07.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: We followed up lamotrigine transport through the placenta and analyzed maternal and umibilical cord concentrations, its ratio and maternal lamotrigine clearance in monotherapy and in combinations. Methods: Maternal and umbilical cord concentrations were analyzed during delivery in a cohort of 63 women between 2001 and 2009. The request forms for routine therapeutic drug monitoring were used as the data source. Maternal concentrations were used for the estimation of apparent oral clearance and paired infant and maternal concentrations for estimation of the infant (umibilical cord)/maternal serum concentration ratio. Results: The lamotrigine infant/maternal serum concentration ratio ranged in monotherapy from 0.40 to 1.38 (median 0.91). The ratio in monotherapy showed a possible distribution to two subgroups. Concomitant administration of valproic acid significantly increased both maternal and infant lamotrigine concentrations and significantly decreased lamotrigine clearance by about 65%. Co-medication with carbamazepine increased lamotrigine clearance non-significantly. Highly significant correlations were found between maternal and umbilical cord lamotrigine concentrations, both in monotherapy and in the lamotrigine + valproic acid combination. Infant concentrations of valproic acid were found to be about 30% higher and infant concentrations of carbamazepine were found to be about 20% lower than maternal concentrations. Conclusions: Our data from the large cohort showed the interindividual variability of umbilical cord/maternal serum concentration ratio in lamotrigine monotherapy caused probably by the different activity of the placental lamotrigine metabolizing enzymes UGT1A4 and 2B7 associated with genetic polymorphism. The potential teratogenic effect of lamotrigine combination with valproic acid could be associated with the higher lamotrigine and valproic acid concentrations in the fetus. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 50 条
  • [21] Smoking reduces serum levels of lamotrigine
    Reinsberger, Claus
    Dorn, Thomas
    Kraemer, Guenter
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2008, 17 (07): : 651 - 653
  • [22] Monitoring topiramate concentrations at delivery and during lactation
    Kacirova, Ivana
    Grundmann, Milan
    Brozmanova, Hana
    Koristkova, Blanka
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 138
  • [23] Simple dietary criteria to improve serum n-3 fatty acid levels of mothers and their infants
    Hautero, Ulla
    Poussa, Tuija
    Laitinen, Kirsi
    PUBLIC HEALTH NUTRITION, 2017, 20 (03) : 534 - 541
  • [24] Lamotrigine serum levels: Ceiling effect in people with epilepsy in remission?
    D'Anto, Jennifer
    Wnuk, Wlodzimierz
    Rossetti, Andrea O.
    Decosterd, Laurent A.
    Buclin, Thierry
    Novy, Jan
    EPILEPSY & BEHAVIOR, 2017, 74 : 41 - 44
  • [25] Valproic Acid Concentrations in Mothers, Colostrum and Breastfed Infants during the Early Postpartum Period: Comparison with Concentrations Determined during Delivery and in the Mature Milk Period
    Kacirova, Ivana
    Grundmann, Milan
    Brozmanova, Hana
    PHARMACEUTICS, 2021, 13 (12)
  • [26] Correlation of elevated lamotrigine and levetiracetam serum/plasma levels with toxicity: A long-term retrospective review at an academic medical center
    Wood, Kelly E.
    Palmer, Kendra L.
    Krasowski, Matthew D.
    TOXICOLOGY REPORTS, 2021, 8 : 1592 - 1598
  • [27] UGT polymorphisms and lamotrigine clearance during pregnancy
    Petrenaite, Vaiva
    Ohman, Inger
    Ekstrom, Lena
    Saebye, Ditte
    Hansen, Thomas Folkmann
    Tomson, Torbjorn
    Sabers, Anne
    EPILEPSY RESEARCH, 2018, 140 : 199 - 208
  • [28] Prospective study on concentration-efficacy and concentration-toxicity:: correlations with lamotrigine serum levels
    Fröscher, W
    Keller, F
    Vogt, H
    Krämer, G
    EPILEPTIC DISORDERS, 2002, 4 (01) : 49 - 55
  • [29] Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery
    Ebert, Thomas
    Stepan, Holger
    Schrey, Susanne
    Kralisch, Susan
    Hindricks, Janka
    Hopf, Lisa
    Platz, Martin
    Lossner, Ulrike
    Jessnitzer, Beate
    Drewlo, Sascha
    Blueher, Matthias
    Stumvoll, Michael
    Fasshauer, Mathias
    CYTOKINE, 2014, 65 (02) : 153 - 158
  • [30] Data on the relationship between lamotrigine and levetiracetam serum/plasma levels and toxicity: Experience at an academic medical center
    Wood, Kelly E.
    Palmer, Kendra L.
    Krasowski, Matthew D.
    DATA IN BRIEF, 2021, 39